Explorer les evidences

9,1 %In 1990, 9.1% of 10,000-person communities in western Kenya were HIV prevalence outliers.

KenyaVIH/sidaobservé 1990publié 2025PLoS computational biologyPubMeddocument de 2 observations

3,78 odds_ratioOmicron was associated with cough (odds ratio 3.78; 95% CI 1.1–16.74, p = 0.026) relative to other SARS-CoV-2 variants of concern in Laikipia county, Kenya.

KenyaCOVID-19observé 24th April to 31st December 2021publié 2023Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-Coeurope_pmcdocument de 10 observations

40 %RDTs were most reliable for classifying districts and schools into prevalence categories of 40% and least reliable in the 1–4.9% category.

Kenyapaludismepublié 2012The American journal of tropical medicine and hygieneeurope_pmcdocument de 3 observationsDOI 10.4269/ajtmh.2012.12-0215

Most of the patients who died after discharge had been admitted with a diagnosis of gastroenteritis.

Kenyagastroenteritispublié 2000Tropical medicine & international health : TM & IHeurope_pmcdocument de 3 observations

14 000 cases_per_yearSickle Cell Disease poses a significant healthcare challenge in Kenya, with about 14,000 new cases annually.

Kenyadrépanocytosepublié 2025Studies in health technology and informaticsPubMed

32,8 %In Kenya, 32.8% of participants reported a change in frequency of blood glucose testing during the COVID-19 pandemic.

Kenyadiabète de type 2observé 2022publié 2024Global health actionPubMeddocument de 8 observations

8,3 %Among 422 eligible patients with newly diagnosed HIV-related Kaposi sarcoma in Uganda and Kenya, refusal or unsuitability to consent was the reason for not performing rapid case ascertainment in 8.3% of cases.

KenyaHIV-related Kaposi sarcomapublié 2021Cancer epidemiologyPubMeddocument de 7 observations

64 %Among 241 adults newly diagnosed with Kaposi sarcoma in Kenya and Uganda from 2016 to 2019, 64% qualified as WHO severe/symptomatic Kaposi sarcoma.

Kenyasarcome de Kaposiobservé 2016 to 2019publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 12 observations

16 017 non-responsesAmong 299 pregnant women living with HIV in Kenya, there were 16,017 (51%) instances of non-response to interactive text messages during the intervention period.

KenyaVIH/sidapublié 2024BMC pregnancy and childbirthPubMeddocument de 6 observations

730 000 000 USDInternational financing for malaria control increased from $0.73 billion to $1.94 billion since 2007.

Kenyapaludismeobservé 2007publié 2010Lancet (London, England)europe_pmcdocument de 8 observations

Khat chewing was significantly associated with reported hallucinations (p = 0.0017).

Kenyahallucinationspublié 2019BMC PsychiatryOpenAlexdocument de 9 observationsDOI 10.1186/s12888-019-2118-3

Plasmodium falciparum parasite prevalence among children aged 2–10 years (PfPR2-10) along the Kenyan coast began to decline from 1998 onwards until 2011.

Kenyapaludismeobservé 1998 to 2011publié 2015PloS oneeurope_pmcdocument de 4 observations

70,9 per_100_fetus-yearsThe incidence rate of preterm birth was 70.9 per 100 fetus-years among 4084 women in a prospective study in Western Kenya.

Kenyapreterm birthpublié 2025BMC pregnancy and childbirthPubMeddocument de 5 observations

5,3 %Hydrocele was present in 5.3% of adult males in the low endemicity community.

Kenyahydrocelepublié 2002The American journal of tropical medicine and hygieneeurope_pmcdocument de 12 observationsDOI 10.4269/ajtmh.2002.66.550

Less than half of the included patients were alive 3 years after a cancer diagnosis for leukaemia in sub-Saharan Africa.

Kenyaleukemiapublié 2024The Lancet. Global healtheurope_pmcdocument de 12 observations

4,4 %VMMC uptake in the combined interpersonal communication and dedicated service outlets arm was 4.4%.

KenyaVIH/sidapublié 2023PloS onePubMeddocument de 7 observations

15,4 %In the APS+HIVST arm, 15.4% (326/2111) of tested partners received provider-delivered HIV testing.

KenyaVIH/sidaobservé 2021publié 2024Journal of the International AIDS SocietyPubMeddocument de 15 observations

21 %Prevalence of Plasmodium falciparum infection was 21% by rapid diagnostic test.

Kenyapaludismepublié 2026The American journal of tropical medicine and hygienePubMeddocument de 3 observations

460 758 peopleA total of 460,758 (57.4%) people living with HIV initiated antiretroviral therapy.

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 12 observations

6 792 EU/mLGeometric mean titres of IgG antibodies to the circumsporozoite antigen in infants were 6792 (5310 to 8687) EU/mL at day 456 after a booster dose at day 421.

Kenyapaludismepublié 2023Wellcome open researcheurope_pmcdocument de 3 observations

40,7 %Among 29 confirmed cases of endocervical adenocarcinoma diagnosed at AKUHN between July 2017 and July 2018, high-risk HPV type 16 alone was positive in 11 (40.7%) cases.

Kenyaendocervical adenocarcinomaobservé July 2017 to July 2018publié 2022Annals of clinical and laboratory sciencePubMeddocument de 5 observations

91 casesOf 91 cases identified using real-time PCR, 83 near-complete genomes were assembled.

KenyaHuman adenoviruses type Fobservé 2013 and 2022publié 2022Genomic epidemiology of Human Adenovirus F40 and F41 in Coastal Kenya: A retrospective hoseurope_pmcdocument de 6 observationsDOI 10.1101/2022.10.21.22281250

22 %The overall prevalence of HIV was 22% among women with vaginal discharge in Nairobi, Kenya.

KenyaVIH/sidaobservé 1997publié 2000Sexually transmitted infectionseurope_pmcdocument de 9 observations

3,6 %Among young females who do not sell sex (YFNS) in Mombasa, Kenya, 3.6% were living with HIV.

KenyaVIH/sidaobservé 2015publié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 11 observations

19,7 %In Kenya, 19.7% of new cancer cases among women are attributed to cervical cancer.

Kenyacancer du col de l'utéruspublié 2025Acta cytologicaPubMeddocument de 7 observations